van der Vloet, L., Hilaire, P. B. S., Bouillod, C., Isin, E. M., Heeren, R. M. A., & Vandenbosch, M. (2025). In Drug Discovery Today (Vol. 30, Issue 1, p. 104275). Elsevier BV.
Publication Area of Interest: Drug Development
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma
Multiplex and multiomic MS imaging of drugs, metabolites, and immunolabeled pathogenic protein markers within a single tissue section
ASMS 2024 • Prem Shankar; Reina N Paez; David Beaver; Bandana Bera; Brendan Prideaux
Combining Drug and Targeted Protein Imaging to Uncover Molecular Changes Associated with Cancer Treatment
ASMS 2024 • Erin H. Seeley, Catherine A. Kita, Gargey Yagnik, Kenneth J. Rothschild, Mark J. Lim, Rahul A. Sheth
Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response
Pearce, S.M.; Cross, N.A.; Smith, D.P.; Clench, M.R.; Flint, L.E.; Hamm, G.; Goodwin, R.; Langridge, J.I.; Claude, E.; Cole, L.M. Metabolites 2024, 14, 315. • Drug study, Multiomic, Multimodal, Tumor Spheroids
Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma
Stillger, M. N., Li, M. J., Hönscheid, P., von Neubeck, C., & Föll, M. C. (2024). In PROTEOMICS (Vol. 24, Issues 12–13). Wiley. • Multiomic and Multimodal techniques